Randomized, Double-Blind, Placebo Controlled Trial of Voraxaze™ in Patients With a Delayed MTX Clearance

Trial Profile

Randomized, Double-Blind, Placebo Controlled Trial of Voraxaze™ in Patients With a Delayed MTX Clearance

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 09 Jun 2014

At a glance

  • Drugs Glucarpidase (Primary) ; Methotrexate
  • Indications Haematological malignancies; Solid tumours
  • Focus Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 10 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top